R. Vinall

发表

Applying pharmacogenomics in drug discovery and development

R. Vinall, 2016 .

MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples

P. Ghosh, R. Vinall, B. Durbin-Johnson, 2017, BMC Veterinary Research.

Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma.

Michael S Kent, R. deVere White, R. Vinall, 2012, American journal of veterinary research.

Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy

C. Tepper, R. deVere White, R. Gandour-Edwards, 2016, Genes & cancer.

Androgen Receptor-Mediated Nuclear Transport of NRDP1 in Prostate Cancer Cells Is Associated with Worse Patient Outcomes

P. Ghosh, R. Vinall, B. Durbin-Johnson, 2021, Cancers.

Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen‐dependent and independent prostate cancer cell lines

C. Tepper, R. deVere White, P. Mack, 2008, BJU international.

Investigation of cell compatibility of titanium test surfaces to fibroblasts

R. G. Richards, R. Vinall, B. Gasser, 1995 .

Combination Treatment of Prostate Cancer Cell Lines with Bioactive Soy Isoflavones and Perifosine Causes Increased Growth Arrest and/or Apoptosis

P. Ghosh, R. Vinall, P. Lara, 2007, Clinical Cancer Research.

Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization.

C. Tepper, H. Kung, R. deVere White, 2012, Endocrine-related cancer.

Inappropriate activation of androgen receptor by relaxin via β-catenin pathway

C. Tepper, H. Kung, R. Gandour-Edwards, 2008, Oncogene.

Regulation of articular chondrocyte phenotype by bone morphogenetic protein 7, interleukin 1, and cellular context is dependent on the cytoskeleton.

S. Lo, A. Reddi, R. Vinall, 2002, Experimental cell research.

Use of RNA-Seq and a Transgenic Mouse Model to Identify Genes Which May Contribute to Mutant p53-Driven Prostate Cancer Initiation

A. Borowsky, C. Tepper, R. Vinall, 2022, Biology.

Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression

A. Borowsky, R. deVere White, M. Shen, 2012, Disease Models & Mechanisms.

Profiling of gene expression changes caused by p53 gain‐of‐function mutant alleles in prostate cancer cells

J. Gregg, C. Tepper, H. Kung, 2005, The Prostate.

MicroRNAs and their potential for translation in prostate cancer.

C. Tepper, R. deVere White, R. Vinall, 2009, Urologic oncology.

The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7

C. Tepper, R. Gandour-Edwards, R. Vinall, 2006, Oncogene.

Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators

C. Tepper, P. Ghosh, R. Vinall, 2019, International journal of molecular sciences.

Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.

A. Chinnaiyan, C. Tepper, R. Mehra, 2010, Cancer research.

Nrdp 1-Mediated Regulation of ErbB 3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells

A. Chinnaiyan, C. Tepper, R. Mehra, 2010 .

MiR‐34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53‐Rb pathway status

R. deVere White, R. Vinall, C. Pan, 2012, International journal of cancer.

The Androgen Receptor is a negative regulator of eIF4E Phosphorylation at S209: Implications for the use of mTOR inhibitors in advanced prostate cancer

C. Tepper, R. deVere White, P. Ghosh, 2017, Oncogene.

Genistein Combined Polysaccharide (GCP) Can Inhibit Intracrine Androgen Synthesis in Prostate Cancer Cells

S. Kotchoni, P. Ghosh, R. Vinall, 2020, Biomedicines.

GCP‐mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor‐dependent and ‐independent mechanisms

C. Tepper, P. Mack, R. Vinall, 2007, The Prostate.

Dual Blockade of PKA and NF–κB Inhibits H2 Relaxin-Mediated Castrate-Resistant Growth of Prostate Cancer Sublines and Induces Apoptosis

C. Tepper, R. Gandour-Edwards, P. Ghosh, 2011, Hormones & cancer.

Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway.

C. Tepper, H. Kung, R. deVere White, 2008, Oncogene.

Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer

K. Turteltaub, P. Chain, R. Vinall, 2016, PloS one.

Glycomic Approach for Potential Biomarkers on Prostate Cancer: Profiling of N-Linked Glycans in Human Sera and pRNS Cell Lines

Scott R. Kronewitter, K. Lam, C. Lebrilla, 2009, Disease markers.

Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3

R. deVere White, P. Ghosh, R. Vinall, 2011, Clinical Cancer Research.

Cancer Therapy : Preclinical Dual EGFR / HER 2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB 3

P. Ghosh, R. Vinall, R. D. White, 2011 .

XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies

R. Weiss, R. Gandour-Edwards, P. Ghosh, 2018, Oncotarget.

The Effect of BMP on the Expression of Cytoskeletal Proteins and Its Potential Relevance

A. Reddi, R. Vinall, 2001, The Journal of bone and joint surgery. American volume.

The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidence.

R. deVere White, P. Ghosh, M. Mudryj, 2015, The Journal of urology.

MiR‐34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53‐Rb pathway status

R. deVere White, R. Vinall, C. Pan, 2012, International journal of cancer.

Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3

R. deVere White, P. Ghosh, R. Vinall, 2011, Clinical Cancer Research.